Medical Blog About Treatment Abroad

Breast cancer immunotherapy represents a groundbreaking advancement in oncology, encompassing various innovative approaches to cancer treatment. German clinics are at the forefront of implementing these advanced therapies, from immune checkpoint inhibitors to dendritic cell vaccines – the latter made possible by Ralph Steinman... 

Transarterial Chemoembolization (TACE) is one of the most widely used and effective minimally invasive treatments for liver tumors and other cancers with localized blood supply. As technology and oncology have evolved, TACE has become even more precise and personalized in 2025, offering patients new hope - especially when surgery...

Ovarian cancer is one of the most common gynecologic cancers, it ranks second in incidence among all types of cancer. It is most often diagnosed in women over 40-45 years old. Screening and increased awareness are crucial in detecting ovarian cancer early before it reaches stage 4, a terminal phase often accompanied by severe pain...

In Germany, prostate cancer is treated in large multidisciplinary university hospitals, as well as specialized centers of prostate cancer treatment and radiation therapy. With over 50 specialized centers achieving 5-year survival rates above 90% for localized disease, Germany offers advanced therapeutic options.

Among middle-aged and elderly men worldwide, prostate cancer (PCa) stands as a significant health threat. The American Cancer Society's prognosis expects around 313,780 new prostate cancer cases in 2025, and a huge number of approximately 35,770 men are expected to die from this disease. This translates to one man being...

Duodenal cancer is an aggressive malignancy that requires from healthcare professionals expertise beyond standard approaches. According to the statistics, the survival is falling to just 11-19% in advanced cases from 80% in early stages. Traditional duodenum cancer treatment such as Whipple procedure is the approved basis but newer...

Lung cancer is the second most common type of cancer in men and women and is responsible for approximately 13% of all new cancer cases worldwide. Survival rate over five years is very much based on diagnosis stage. For localized early-stage cancers, it is more than 90%. But for advanced metastatic illness, unfortunately, it dips below 10%.

Renal cell carcinoma (RCC) accounts for approximately 90% of all kidney cancers and remains one of the ten most common cancers worldwide. In 2022 alone, more than 435,000 new cases were diagnosed globally, with over 156,000 deaths attributed to the disease. The incidence has been steadily increasing, particularly in high-income...